Anglo French Drugs Share Price Today

Anglo-French Drugs & Industries Limited Unquoted Shares - Company Overview

Anglo–French Drugs & Industries Limited (AFDIL) is a pharmaceutical company established in 1923 and based in Bengaluru. The company is mainly engaged in the manufacturing of pharmaceutical formulations. Pharmaceutical formulation is a process in which different chemical substances including the active drug are mixed with each other to produce a final medicinal product.

Anglo–French Drugs & Industries Limited is one of the most prominent pharmaceutical companies recognized not only in India but also at a global level. Anglo-French Drugs & Industries Limited is the first company to manufacture single vitamin injections and a combination of B-complex vitamins in India.

The company focuses mainly on vitamins, sleep-inducing agents, antiepileptics and antioxidants, cold and cough preparations, protein food supplements, antibiotics, anti-inflammatory drugs, digestive enzymes, and calcium supplements.

Anglo–French Drugs & Industries Limited serves around 75,000 medical practitioners in India annually. The company has a well-distributed network of 24 clearing and forwarding agents and 1600 stockists. The products of Anglo-French Drugs & Industries Limited are available at over 50,000 stores in India. The company has a presence in 16 countries across Eastern Europe, South East Asia & Africa.

Equity shares of Anglo–French Drugs & Industries Limited are listed on the Metropolitan Stock Exchange of India (MSEI).

Anglo-French Drugs & Industries Unlisted Share Details as of March 31, 2025

Anglo-French Drugs & Industries Incorporation Details 

Principal Business Activities of Anglo-French Drugs & Industries

Anglo-French Drugs & Industries Boards of Directors

Mr. Abhay Kanoria (Chairman & Managing Director)

Mr. Uddhav Kanoria (President & Whole-time Director)

Mr. Nirbhay Kanoria (Whole-time Director)

Mr. Sanatkumar Manjunath Shirali (Independent Director)

Mr. Nalagath Ahmedali (Independent Director)

Mrs. Neha Gada (Independent Director)

Mr. Shashikant N More (Nominee Director)

Dr. Rajeshwar B Smarta (Additional Independent Director)

Mr. Rakesh P Kanyadi (Additional Non-Executive Director)

Anglo-French Drugs & Industries Particulars Of Subsidiary Companies

Anglo-French Drugs & Industries Shareholding Pattern (As of 31-03-2025)

Industry Outlook

Indian Pharmaceutical market ranks as 3rd largest in the world in terms of volume and 14th largest in terms of value. Healthcare has become one of the largest sectors of the Indian economy, in terms of both employment and revenue. India is known as the Pharmacy of the world and is the largest provider of generic drugs at a global level. The pharmaceutical industry of India supplies over 50% of global demand for various vaccines, 40% of generic demands in the USA, and 25% of all the medicines in the United Kingdom. Excellent Research & Development, low cost of labor, availability of management and technical personnel, and local equipment’s availability have helped India to manufacture pharma products at a very low cost.

The Indian healthcare market saw a 3 fold jump in terms of value. The growth can be attributed to rising income, greater health awareness, increased precedence of lifestyle disease, and Indian prominence in making medicinal products for the treatment of COVID 19.

After the onset of COVID-19, the Indian pharmaceutical sector became the busiest sector in the Indian economy. The pandemic proved to be a boon in disguise for the Indian pharmaceutical sector.

FAQ's on Anglo French Drugs

Q: What is the face value of Anglo-French Drugs & Industries Ltd shares?
Answer: The face value of Anglo-French Drugs & Industries Ltd is ₹10 per equity share.

Q: What is the minimum lot size for buying Anglo-French Drugs shares through WWIPL?
Answer: The minimum investment lot size is 100 equity shares.

Q: How can I buy Anglo-French Drugs unlisted shares through WWIPL?
Answer: Investors can complete KYC, confirm the transaction with WWIPL, transfer funds, and receive the shares directly in their Demat account.

Q: Why should I buy Anglo-French Drugs shares through WWIPL?
Answer: WWIPL offers transparent pricing, secure transactions, seamless Demat transfers, and dedicated support throughout the investment process.

Q: Is investing in Anglo-French Drugs & Industries Ltd a good idea?
Answer: Investors generally evaluate Anglo-French Drugs based on its established pharmaceutical business, financial performance, export presence, product portfolio, and long-term growth potential.

Q: Why do investors buy Anglo-French Drugs shares before a potential IPO or increased market participation?
Answer: Investors seek exposure to a long-established pharmaceutical company with the potential for value creation through business growth and improved market liquidity.

Q: What business does Anglo-French Drugs & Industries Ltd operate in?
Answer: Anglo-French Drugs manufactures and markets pharmaceutical formulations, including vitamins, antibiotics, anti-inflammatory drugs, protein supplements, digestive enzymes, and calcium supplements. The company sells its products through over 50,000 retail outlets in India and exports to 16 countries.

Q: What makes Anglo-French Drugs different from other unlisted pharmaceutical companies?
Answer: The company has over a century of operating history, a diversified pharmaceutical portfolio, and an established domestic and international distribution network.

Q: What are the key growth drivers for Anglo-French Drugs & Industries Ltd?
Answer: Growth in the Indian pharmaceutical market, increasing healthcare spending, export expansion, product diversification, and rising demand for generic medicines are key growth drivers.

Q: What factors affect the valuation of Anglo-French Drugs shares?
Answer: Revenue growth, profitability, product portfolio, export performance, operating margins, regulatory compliance, and industry outlook are key valuation drivers.

Q: Are Anglo-French Drugs shares available in Demat form?
Answer: Yes. Shares purchased through WWIPL are transferred directly to the investor's Demat account.

Q: Can I sell my Anglo-French Drugs shares through WWIPL?
Answer: Yes. WWIPL facilitates both buying and selling of unlisted shares, subject to market demand and availability.

Q: What documents are required to buy Anglo-French Drugs shares through WWIPL?
Answer: Investors generally need PAN, Aadhaar, Client Master Report CMR, and bank account details to complete the transaction.

Q: What are the risks of investing in Anglo-French Drugs shares?
Answer: Investors should consider regulatory risks, pricing pressure, competition, compliance requirements, and liquidity constraints associated with unlisted shares.

Q: How does WWIPL help investors track Anglo-French Drugs investments?
Answer: WWIPL provides company updates, transaction assistance, market insights, and investment support to help investors stay informed.

Q: How long does it take for Anglo-French Drugs shares purchased through WWIPL to be credited to a Demat account?
Answer: Shares are generally transferred to the investor's Demat account after successful completion and verification of the transaction.

Q: What should investors evaluate before investing in Anglo-French Drugs & Industries Ltd?
Answer: Investors should assess the company's financial performance, product portfolio, export presence, profitability, valuation, management quality, and long-term growth prospects.

Q: Can Anglo-French Drugs benefit from the growth of India's pharmaceutical industry?
Answer: Yes. Rising healthcare expenditure, growing demand for branded and generic medicines, and expanding export opportunities may support the company's long-term growth.